Literature DB >> 15217157

Inclusion bodies: formation and utilisation.

Beatrix Fahnert1, Hauke Lilie, Peter Neubauer.   

Abstract

The efficient in vivo folding of many heterologous proteins is a major bottleneck of high level production in bacterial hosts and simple optimisation protocols have not been available yet. Therefore, inclusion body (IB) based processes play a major role as a potential strategy for the production of complex recombinant proteins. These processes combine the advantages of a high accumulation of the target protein in well-characterised bacteria such as Escherichia coli, efficient strategies for IB isolation, purification and in vitro protein refolding without the need of complicated coexpression systems. Recent advances in the molecular physiology of IB formation and resolubilisation allow straight-forward optimisation of fermentation processes to obtain a high-quality product. In addition, simple strategies have been developed to optimise the purification and renaturation of disulfide bond containing proteins making a fast transfer of such processes into the industrial production scale realistic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217157     DOI: 10.1007/b93995

Source DB:  PubMed          Journal:  Adv Biochem Eng Biotechnol        ISSN: 0724-6145            Impact factor:   2.635


  49 in total

1.  Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein.

Authors:  Thu Trang Thi Vu; Bon-Kyung Koo; Jung-A Song; Seon-Ha Chong; Cho Rong Park; Minh Tan Nguyen; Boram Jeong; Han-Bong Ryu; Jae Young Seong; Yeon Jin Jang; Robert Charles Robinson; Han Choe
Journal:  Mol Biol Rep       Date:  2014-11-13       Impact factor: 2.316

2.  Dynamic polar sequestration of excess MurG may regulate enzymatic function.

Authors:  Allison M Michaelis; Zemer Gitai
Journal:  J Bacteriol       Date:  2010-07-19       Impact factor: 3.490

3.  Enzyme clustering accelerates processing of intermediates through metabolic channeling.

Authors:  Michele Castellana; Maxwell Z Wilson; Yifan Xu; Preeti Joshi; Ileana M Cristea; Joshua D Rabinowitz; Zemer Gitai; Ned S Wingreen
Journal:  Nat Biotechnol       Date:  2014-09-28       Impact factor: 54.908

4.  Expression and in vitro functional analyses of recombinant Gam1 protein.

Authors:  Gustavo A Avila; Daniel H Ramirez; Zacariah L Hildenbrand; Pedro Jacquez; Susanna Chiocca; Jianjun Sun; German Rosas-Acosta; Chuan Xiao
Journal:  Protein Expr Purif       Date:  2014-10-16       Impact factor: 1.650

5.  L-Arginine increases the solubility of unfolded species of hen egg white lysozyme.

Authors:  Ravi Charan Reddy K; Hauke Lilie; Rainer Rudolph; Christian Lange
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

6.  Protein solubility and differential proteomic profiling of recombinant Escherichia coli overexpressing double-tagged fusion proteins.

Authors:  Chung-Hsien Cheng; Wen-Chien Lee
Journal:  Microb Cell Fact       Date:  2010-08-28       Impact factor: 5.328

7.  Novel approach of high cell density recombinant bioprocess development: optimisation and scale-up from microliter to pilot scales while maintaining the fed-batch cultivation mode of E. coli cultures.

Authors:  Juozas Siurkus; Johanna Panula-Perälä; Uwe Horn; Mario Kraft; Renata Rimseliene; Peter Neubauer
Journal:  Microb Cell Fact       Date:  2010-05-20       Impact factor: 5.328

8.  Chaperone-fusion expression plasmid vectors for improved solubility of recombinant proteins in Escherichia coli.

Authors:  Christos A Kyratsous; Saul J Silverstein; Christine R DeLong; Christos A Panagiotidis
Journal:  Gene       Date:  2009-03-26       Impact factor: 3.688

Review 9.  Toxins from cone snails: properties, applications and biotechnological production.

Authors:  Stefan Becker; Heinrich Terlau
Journal:  Appl Microbiol Biotechnol       Date:  2008-03-14       Impact factor: 4.813

10.  A HUPO test sample study reveals common problems in mass spectrometry-based proteomics.

Authors:  Alexander W Bell; Eric W Deutsch; Catherine E Au; Robert E Kearney; Ron Beavis; Salvatore Sechi; Tommy Nilsson; John J M Bergeron
Journal:  Nat Methods       Date:  2009-06       Impact factor: 28.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.